共 17 条
[1]
Baldessarine R.J., Drugs and the treatment of psychiatric disorders, The pharmacologic basis of therapeutics, (1985)
[2]
Brunner H.R., Waeber B., Nussberger J., Principles and practice of angiotensin-converting enzyme inhibitors, Cardiovascular drug therapy, pp. 732-760, (1990)
[3]
Campbell A.J., Drug treatment as a cause of falls in old age. A review of the offending agents, Drugs & Aging, 1, pp. 289-302, (1991)
[4]
Preliminary report: effect of encainide and flecainide on mortality in a randomised trial of arrhythmia suppression after myocardial infarction, New England Medical Journal, 312, pp. 406-412, (1989)
[5]
Cornoni-Huntley J., LaCroix A.Z., Havlik R.J., Race and sex differentials in the impact of hypertension in the United States: the National Health and Nutrition Examination Survey I, Epidemiologic Follow-up Study (1982–1984), Archives of Internal Medicine, 149, pp. 780-788, (1989)
[6]
Report of the Joint National Committee on the Detection, Evaluation and Treatment of High Blood Pressure, Archives of Internal Medicine, 148, pp. 1023-1038, (1988)
[7]
Frishman W.H., Beta-adrenergic blockers, Medical Clinics of North America, 72, pp. 37-54, (1988)
[8]
Mader S.L., Aging and postural hypotension, Journal of the American Geriatric Society, 37, pp. 129-137, (1989)
[9]
Mader S.L., Orthostatic hypotension, Medical Clinics of North America, 73, pp. 1337-1349, (1989)
[10]
McMahon G.F., Alpha<sub>1</sub>blocking agents, In Management of essential hypertension,chapter IX, pp. 501-531, (1990)